Alisa Briones
Family Medicine · Fort Wayne, INNPI 1740821925
Payments from drug & device makers
Across 113 payments — averaging $16.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$569
- Corium, LLC$249
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$195
- Novo Nordisk$137
- Tris Pharma Inc$131
- Gilead$74
- plus $526 from 16 others
What the payments were for
- Food & beverage$1,881100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 39 | $569 |
| Corium, LLC | 20 | $249 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 16 | $195 |
| Novo Nordisk | 3 | $137 |
| Tris Pharma Inc | 7 | $131 |
| Gilead | 4 | $74 |
| Otsuka America Pharmaceutical, Inc. | 3 | $65 |
| Alkermes, Inc. | 3 | $63 |
| Mallinckrodt Hospital Products Inc. | 1 | $59 |
| Corcept Therapeutics | 2 | $54 |
| Sunovion Pharmaceuticals Inc. | 2 | $46 |
| Indivior Inc. | 2 | $41 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $31 |
| Supernus Pharmaceuticals, Inc. | 1 | $24 |
| Brainsway USA Inc | 1 | $24 |
| Paratek Pharmaceuticals, Inc. | 1 | $23 |
| Dexcom, Inc. | 1 | $22 |
| Exact Sciences | 1 | $20 |
| Merck | 1 | $15 |
| Lundbeck LLC | 1 | $13 |
| Idorsia Pharmaceuticals US Inc | 1 | $13 |
| Lilly USA, LLC | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Wegovy$110
How this compares
$1,881 in reported general payments places this provider in the 70th percentile of 2,709 family medicine providers in Indiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RybelsusSemaglutide | 24 | $25,463 |
| OzempicSemaglutide | 18 | $19,213 |
| JardianceEmpagliflozin | 47 | $17,971 |
| JanuviaSitagliptin Phosphate | 13 | $12,186 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 13 | $8,797 |
| LinzessLinaclotide | 12 | $6,689 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 15 | $2,084 |
| Gabapentin | 82 | $1,534 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 53 | $1,393 |
| Levetiracetam | 30 | $876 |
| Ventolin HfaAlbuterol Sulfate | 12 | $749 |
| Atorvastatin Calcium | 110 | $739 |
| Pantoprazole Sodium | 37 | $656 |
| Levothyroxine Sodium | 64 | $644 |
| Omeprazole | 97 | $619 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskRybelsus, Ozempic | $137 | $44,67642 claims |
| MerckJanuvia | $15 | $12,18613 claims |
| AbbVieLinzess | $569 | $6,68912 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 2,709 family medicine providers in Indiana.
Other family medicine in Fort Wayne
- Thomas KintanarFort Wayne$185K
- Brianna SerbusFort Wayne$174K
- Brian AdamsFort Wayne$173K
- Charles CoatsFort Wayne$38K
- Beulah PenumudiFort Wayne$38K
- Blair BrengleIndianapolis$10.6M
- Laura HelmanMishawaka$4M
- J Christopher SartoreEvansville$3.9M
- Hubert ReyesEvansville$3.2M
- David SchultzEvansville$3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.